Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

NCT04706598

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunotherapy, +9 more
Locations
  • Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine Shanghai, Shanghai Municipality, China
  • Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

NCT03732677

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site New Haven, Connecticut, United States
View all 188 locations
View Trial Details
Active, Not Recruiting

Intravesical BCG vs GEMDOCE in NMIBC

NCT05538663

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 229 locations
View Trial Details
Active, Not Recruiting

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

NCT05863351

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT04696731

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

NCT03504163

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Cancer and Blood Pressure Management, CARISMA Study

NCT04467021

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +36 more
Locations
  • Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View all 25 locations
View Trial Details

Related conditions